Stay updated on Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays related topics 'Lung cancer' and 'MedlinePlus Genetics' to guide readers to related resources.
    Difference
    0.1%
    Check dated 2025-12-12T05:43:07.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Lung cancer and the MedlinePlus Genetics related topic were removed from the page's topics/related topics. This reduces disease-specific tagging and cross-links on the page.
    Difference
    0.1%
    Check dated 2025-12-05T02:25:09.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now includes Lung cancer and MedlinePlus Genetics related topics. The revision label was updated from v3.3.1 to v3.3.2.
    Difference
    0.2%
    Check dated 2025-11-27T23:24:05.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; this is a versioning update with no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-20T22:16:19.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The NIH funding-lapse notice and related topic metadata (Lung cancer, related topics, MedlinePlus Genetics) were removed from the page. This removes contextual warnings and some navigational links while leaving the study data unaffected.
    Difference
    0.5%
    Check dated 2025-11-13T15:56:43.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page now lists 'Lung cancer' and 'MedlinePlus Genetics' under Related Topics. These additions are topical keywords that help search and categorization but do not modify the study data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-06T13:24:13.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.